We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$2.36B
AUM Growth
-$1.26B
Cap. Flow
-$1.38B
Cap. Flow %
-58.75%
Top 10 Hldgs %
65%
Holding
177
New
33
Increased
40
Reduced
38
Closed
36

Top Buys

Rank Stock Value
1
GLNG icon
Golar LNG
GLNG
+$33.5M
2
NVDA icon
NVIDIA
NVDA
+$32M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$26.7M
4
HPE icon
Hewlett Packard
HPE
+$22.9M
5
MASI
Masimo
MASI
+$18.6M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$31.8M
2
AAPL icon
Apple
AAPL
+$31.5M
3
KVUE icon
Kenvue
KVUE
+$27.7M
4
TKO icon
TKO Group
TKO
+$25M
5
PRMW
Primo Water Corporation
PRMW
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 14.94%
2 Healthcare 9.49%
3 Consumer Discretionary 8.47%
4 Communication Services 6%
5 Energy 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OFIX icon
101
Orthofix Medical
OFIX
$495M
$1.84M 0.08%
117,891
-131,537
-53% -$2.11M
CCK icon
102
Crown Holdings
CCK
$13.1B
$1.83M 0.08%
19,087
-135,368
-88% -$11.7M
CTRA
103
DELISTED
Coterra Energy
CTRA
$1.82M 0.08%
+75,970
New +$1.87M
MAGN
104
Magnera Corp
MAGN
$497M
$1.78M 0.08%
76,113
+21,903
+40% +$459K
ITOS
105
DELISTED
iTeos Therapeutics
ITOS
$1.71M 0.07%
167,417
+10,523
+7% +$161K
MRVI icon
106
Maravai LifeSciences
MRVI
$985M
$1.57M 0.07%
+189,239
New +$1.64M
VTRS icon
107
Viatris
VTRS
$20.9B
$1.53M 0.07%
131,941
– –
GRAL
108
GRAIL Inc
GRAL
$2.75B
$1.45M 0.06%
105,685
-119,698
-53% -$1.81M
BLMN icon
109
Bloomin' Brands
BLMN
$757M
$1.33M 0.06%
80,320
– –
TENB icon
110
Tenable Holdings
TENB
$3.53B
$1.15M 0.05%
+28,357
New +$1.18M
ZUO
111
DELISTED
Zuora, Inc.
ZUO
$1.11M 0.05%
+128,984
New +$1.14M
OPK icon
112
Opko Health
OPK
$1.06B
$1.08M 0.05%
+726,582
New +$1.08M
TXMD icon
113
TherapeuticsMD
TXMD
$24M
$1.06M 0.04%
636,622
– –
DLTR icon
114
Dollar Tree
DLTR
$25B
$1.05M 0.04%
+14,910
New +$1.36M
FIVN icon
115
FIVE9
FIVN
$2.13B
$1.05M 0.04%
36,413
– –
NUVB icon
116
Nuvation Bio
NUVB
$2.31B
$999K 0.04%
436,437
-800
-0.2% -$2.44K
DBD icon
117
Diebold Nixdorf
DBD
$2.69B
$948K 0.04%
21,228
-14,622
-41% -$605K
VISN
118
Vistance Networks Inc
VISN
$2.65B
$924K 0.04%
151,177
-107,860
-42% -$370K
NATL icon
119
NCR Atleos
NATL
$3.52B
$921K 0.04%
32,299
-274,438
-89% -$7.98M
INFA
120
DELISTED
Informatica
INFA
$917K 0.04%
+36,262
New +$919K
OLO
121
DELISTED
Olo Inc
OLO
$842K 0.04%
169,737
– –
FRSH icon
122
Freshworks
FRSH
$3.21B
$828K 0.04%
72,149
– –
CHRS icon
123
Coherus Oncology
CHRS
$221M
$816K 0.03%
784,449
– –
SNDX icon
124
Syndax Pharmaceuticals
SNDX
$1.73B
$812K 0.03%
42,195
– –
LNSR icon
125
LENSAR
LNSR
$64M
$792K 0.03%
173,004
– –
3 4
5
6 7

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Clearline Capital held 177 positions worth $2.36B, down 35% from $3.62B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Clearline Capital withdrew a net $1.38B in Q3 2024, closing 36 positions and reducing 38 holdings. Its most notable exit was Apple, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Clearline Capital opened a new position in Golar LNG worth $36.9M.

  • Clearline Capital's largest Q3 2024 buy was Golar LNG: 1,002,860 shares worth $36.9M.
  • Clearline Capital added most to MediaAlpha in Q3 2024, an estimated $10.6M increase.
  • Clearline Capital's biggest Q3 2024 reduction was Teladoc Health, cutting an estimated $31.8M.
  • Clearline Capital fully exited Apple in Q3 2024, selling an estimated $31.5M.
  • Clearline Capital's ten largest holdings make up 65% of its $2.36B portfolio in Q3 2024.
  • Clearline Capital opened 33 new positions and closed 36 in Q3 2024.
  • Clearline Capital's portfolio value fell 35% quarter-over-quarter to $2.36B.

Based on Clearline Capital's 13F filing for Q3 2024, filed 14 Nov 2024.